MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin

Gastroenterology

Volumn 143, Issue 1, 2012, Pages

  Zhang, Jinqiang ^a   Han, Chang ^a   Wu, Tong ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biliary Tract; COX 2; Post Transcription Gene Regulation; Prostaglandin

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA 26A; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84862762321     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.03.045     Document Type: Article

References (57)

1. B. Blechacz, G.J. Gores Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 2008 308 321
2. G.J. Gores Cholangiocarcinoma: current concepts and insights Hepatology 37 2003 961 969
3. A.E. Sirica Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy Hepatology 41 2005 5 15
4. E.P. Berthiaume, J. Wands The molecular pathogenesis of cholangiocarcinoma Semin Liver Dis 24 2004 127 137
5. T. Wu Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma Biochim Biophys Acta 1755 2005 135 150
6. K.N. Lazaridis, G.J. Gores Cholangiocarcinoma Gastroenterology 128 2005 1655 1667
7. H. Malhi, G.J. Gores Cholangiocarcinoma: modern advances in understanding a deadly old disease J Hepatol 45 2006 856 867
8. Y. Shaib, H.B. El-Serag The epidemiology of cholangiocarcinoma Semin Liver Dis 24 2004 115 125
9. T. Patel Cholangiocarcinoma - controversies and challenges Nat Rev Gastroenterol Hepatol 8 2011 189 200
10. K. Lim, C. Han, L. Xu Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids Cancer Res 68 2008 553 560
11. K. Ashida, T. Terada, Y. Kitamura Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study Hepatology 27 1998 974 982
12. K. Sugimachi, K. Taguchi, S. Aishima Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma Mod Pathol 14 2001 900 905
13. N. Tokumoto, S. Ikeda, Y. Ishizaki Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas Int J Oncol 27 2005 973 980
14. J. Settakorn, N. Kaewpila, G.F. Burns FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma J Clin Pathol 58 2005 1249 1254
15. S. Hoppler, C.L. Kavanagh Wnt signalling: variety at the core J Cell Sci 120 2007 385 393
16. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
17. M.D. Gordon, R. Nusse Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors J Biol Chem 281 2006 22429 22433
18. R.T. Moon, A.D. Kohn, G.V. De Ferrari WNT and beta-catenin signalling: diseases and therapies Nat Rev Genet 5 2004 691 701
19. M.D. Castellone, H. Teramoto, B.O. Williams Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 2005 1504 1510
20. J. Shao, C. Jung, C. Liu, H. Sheng Prostaglandin E2 stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer J Biol Chem 280 2005 26565 26572
21. B.M. Ryan, A.I. Robles, C.C. Harris Genetic variation in microRNA networks: the implications for cancer research Nat Rev Cancer 10 2010 389 402
22. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 2009 704 714
23. Y. Shimizu, A.J. Demetris, S.M. Gollin Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells Int J Cancer 52 1992 252 260
24. P.D. Storto, S.L. Saidman, A.J. Demetris Chromosomal breakpoints in cholangiocarcinoma cell lines Genes Chromosomes Cancer 2 1990 300 310
25. M. Miyagiwa, T. Ichida, T. Tokiwa A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium In Vitro Cell Dev Biol 25 1989 503 510
26. S. Saijyo, T. Kudo, M. Suzuki Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1 Tohoku J Exp Med 177 1995 61 71
27. T. Wu, C. Han, J.G. Lunz 3rd Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells Hepatology 36 2002 363 373
28. C. Han, J. Leng, A.J. Demetris Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest Cancer Res 64 2004 1369 1376
29. C. Han, T. Wu Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt J Biol Chem 280 2005 24053 24063
30. K. Willert, K.A. Jones Wnt signaling: is the party in the nucleus? Genes Dev 20 2006 1394 1404
31. C.M. Liu, Y.M. Li, M. Semenov Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 2002 837 847
32. O.J. Sansom, V.S. Meniel, V. Muncan Myc deletion rescues Apc deficiency in the small intestine Nature 446 2007 676 679
33. O.A. Botrugno, E. Fayard, J.S. Annicotte Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation Mol Cell 15 2004 499 509
34. T.C. He, T.A. Chan, B. Vogelstein PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell 99 1999 335 345
35. S.S. Kanwar, Y. Yu, J. Nautiyal The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres Mol Cancer 9 2010 212
36. T.C. He, A.B. Sparks, C. Rago Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
37. L. Ma, J. Young, H. Prabhala miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol 12 2010 247 256
38. A. Klaus, W. Birchmeier Wnt signalling and its impact on development and cancer Nat Rev Cancer 8 2008 387 398
39. J.S. Mohamed, M.A. Lopez, A.M. Boriek Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta J Biol Chem 285 2010 29336 29347
40. K. Endo, B.I. Yoon, C. Pairojkul ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions Hepatology 36 2002 439 450
41. N. Hayashi, H. Yamamoto, N. Hiraoka Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm Hepatology 34 2001 638 650
42. S. Chariyalertsak, V. Sirikulchayanonta, D. Mayer Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma Gut 48 2001 80 86
43. C. Sevignani, G.A. Calin, S.C. Nnadi MicroRNA genes are frequently located near mouse cancer susceptibility loci Proc Natl Acad Sci U S A 104 2007 8017 8022
44. G.A. Calin, C. Sevignani, C.D. Dumitru Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci U S A 101 2004 2999 3004
45. G.A. Calin, C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
46. M.S. Nicoloso, R. Spizzo, M. Shimizu MicroRNAs - the micro steering wheel of tumour metastases Nat Rev Cancer 9 2009 293 302
47. A. Esquela-Kerscher, F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
48. Y. Wu, B.M. Evers, B.P. Zhou Small C-terminal domain phosphatase enhances snail activity through dephosphorylation J Biol Chem 284 2009 640 648
49. E.J. Adams, J.A. Green, A.H. Clark Comparison of different scoring systems for immunohistochemical staining J Clin Pathol 52 1999 75 77
50. Y. Shimizu, A.J. Demetris, S.M. Gollin Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells Int J Cancer 52 1992 252 260
51. P.D. Storto, S.L. Saidman, A.J. Demetris Chromosomal breakpoints in cholangiocarcinoma cell lines Genes Chromosomes Cancer 2 1990 300 310
52. M. Miyagiwa, T. Ichida, T. Tokiwa A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium In Vitro Cell Dev Biol 25 1989 503 510
53. S. Saijyo, T. Kudo, M. Suzuki Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1 Tohoku J Exp Med 177 1995 61 71
54. T. Wu, C. Han, J.G. Lunz 3rd Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells Hepatology 36 2002 363 373
55. C. Han, J. Leng, A.J. Demetris Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest Cancer Res 64 2004 1369 1376
56. C. Han, T. Wu Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt J Biol Chem 280 2005 24053 24063
57. K. Lim, C. Han, L. Xu Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids Cancer Res 68 2008 553 560